Definitive Contract 75N95020C00016
Award Date
7/27/20
Potential Completion Date
4/26/21
Potential Value
$225K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541713 - Research and Development in Nanotechnology
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St Paul, MN 55114, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $1,972,191.00 firm fixed price contract to Innovative Surface Technologies Inc. (doing business as Isurtec) for research and development of electrospun biodegradable membrane inserts under the Small Business Innovation Research (SBIR) Program Phase II. The contract is designated as a total small business set-aside. Isurtec is a for-profit manufacturer of...
This SBIR Phase I contract was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Luna Innovations Incorporated, a small business manufacturer, for the development of "RESORB MEMBRANE INSERTS - ADVANCED CELL CULTURE INSERTS WITH BIODEGRADABLE MEMBRANES". The $225,000 firm-fixed-price contract has a period of performance from July 27, 2020 to April 26, 2021. The original solicitation was a total...
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $225,000.00 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Mattek Corp, a for-profit manufacturer of human tissue models and assay kits. The contract is for the development of electrospun biodegradable membrane inserts, to be performed from July 27, 2020 to April 26, 2021. Mattek previously supported federal biomedical research...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Biosurfaces Inc., a for-profit small business, for the delivery of 96-well plate assemblies with a biodegradable membrane. The $894,612.11 firm-fixed-price purchase order contract has a completion date of September 15, 2020. The original solicitation was a combined synopsis/solicitation for commercial items, with the...
This SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) to Intuitive Biosciences Inc. for $299,855. The contract is associated with the NIH and Centers for Disease Control and Prevention (CDC) SBIR solicitation seeking proposals across numerous technical topics to advance public health goals through medical technologies, diagnostics, vaccines, cell therapies and other...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
This is a $300,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products to the federal government. The contract is for the "Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics", which was one of the research topics identified in the...
This is a $168,400.00 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Biosurfaces Inc., a for-profit organization. The contract is for the acquisition of 96-well transwell plates with proprietary bio-spun membrane inserts. This is a non-competitive award to support NCATS' ongoing use of this manufacturer's specialized cell culture products. The solicitation indicated the...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a Small Business Innovation Research (SBIR) Phase II contract to Mimetas US, Inc., a self-certified small disadvantaged business, to develop and evaluate the HEPAPLATE IPS, a high-throughput organ-on-a-chip in vitro hepatotoxicity screening platform. The $1,500,000.00 firm fixed price contract was awarded on February 8, 2018, with a completion date of...